Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension.
Urinary excretion rates of the major norepinephrine metabolites, 3-methoxy-4-hydroxymandelic acid, 3-methoxy-4-hydroxy-phenylglycol and normetanephrine, were determined in 12 normal subjects and 23 patients with neurogenic orthostatic hypotension due to either multiple system atrophy [Shy-Drager Dyndrome (MSA)] or idiopathic orthostatic hypotension (IOH). There were striking and parallel decreases in all catecholamine metabolites in IOH consistent with loss of peripheral sympathetic nerves. Patients with MSA excreted greater amounts of the deaminated metabolites than did the patients with IOH, but most excreted equally low amounts of normetanephrine. The disproportionate decrease in excretion of normetanephrine by patients with MSA is consistent with observations in experimental animals that O-methylation is the primary metabolic route for active released norepinephrine, whereas deamination is the predominant metabolic route for intraneuronal degradation of the catecholamine. The similar proportional decreases in all catecholamine metabolites in patients with IOH (who have no central nervous system deficit) indicates that brain norepinephrine is a source of only a small fraction of urinary norepinephrine metabolites, including 3-methoxy-4-hydroxy-phenylglycol.
D006801:Humans; D007024:Hypotension, Orthostatic / Q000209:etiology / Q000503:physiopathology / Q000652:urine*; D008734:Methoxyhydroxyphenylglycol / Q000652:urine; D008875:Middle Aged; D009422:Nervous System Diseases / Q000150:complications*; D009638:Norepinephrine / Q000652:urine*; D009647:Normetanephrine / Q000652:urine; D012791:Shy-Drager Syndrome / Q000150:complications; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D014642:Vanilmandelic Acid / Q000652:urine
D009647:Normetanephrine; D008734:Methoxyhydroxyphenylglycol; D014642:Vanilmandelic Acid; D009638:Norepinephrine